An Overview of Emtriva (Emtricitabine)
August 23, 2013
Brand Name: Emtriva
Emtricitabine can cause serious, life-threatening side effects. These include lactic acidosis (buildup of acid in the blood) and serious liver problems.
Contact your health care provider right away if you have any of the following symptoms that may signal lactic acidosis:
Contact your health care provider right away if you have any of the following symptoms that may signal liver problems:
Emtricitabine is not approved for the treatment of hepatitis B virus (HBV) infection. People infected with HBV who take emtricitabine and then stop taking it may get severe worsening of their HBV infections.
While taking emtricitabine, it is important to keep all of your appointments with your health care provider.
What is emtricitabine?
Emtricitabine is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults, children, and infants. Emtricitabine is always used in combination with other anti-HIV medicines.
Emtricitabine is a type of anti-HIV medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by blocking HIV reverse transcriptase, an HIV enzyme. This prevents HIV from replicating and lowers the amount of HIV in the blood.
Emtricitabine does not cure HIV/AIDS. It is not known if emtricitabine reduces the risk of passing HIV to other people.
The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, prepared by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the HIV Medicine Association of the Infectious Diseases Society of America (IDSA-HIVMA), includes recommendations for the "off-label" use of emtricitabine to treat HBV infection in people who are also receiving combination antiretroviral therapy (ART) for HIV infection. In addition to emtricitabine, the ART regimen should include another drug that is effective against both HBV and HIV. Emtricitabine should not be used to treat HBV in HIV-infected individuals who are not receiving ART.
What should I tell my health care provider before taking emtricitabine?
Before taking emtricitabine, tell your health care provider:
This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.